The first and only agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsy,* LYMPHOSEEK provides accurate and precise lymph node identification in patients with solid tumors.
Mechanism of Action
Clinical Efficacy: Solid Tumors
Review this section for more information on how to use LYMPHOSEEK in your patients to assist in the localization of lymph nodes draining a primary tumor site.
Dosing and Administration
Cardinal Health Nuclear Pharmacy Services Resources
This page is intended to serve as notice under 35 U.S.C. §287(a). The following U.S. patents apply to our products:
U.S. Patent Nos.: 6,409,990; 8,545,808; 9,439,985. Additional patents pending.